The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, April 2010

Altmetric Badge

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 53 Dimensions

Readers on

mendeley: 42 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE

Application WO-2012068096-A3

World Intellectual Property Organisation (WIPO)

BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE

Application WO-2012068106-A3

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.